Congressional disclosures
John Garamendi
Free on iOS and Android.
Recent disclosures
9 of 9 on record · traded Jan 5, 2016 to Jan 14, 2022Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 26, 2026), not the member's result. Not investment advice.
| Asset | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| SQSpouse | Stock | Sale | $1,001 - $15,000 | -42.6%After the saleS&P 500 +63.5% · -106.2 pts vs S&P 500Now trading as XYZ | Jan 14, 2022 | Jan 21, 2022 | 7d |
| TWTRSpouseCommunication Services | Stock | Sale | $1,001 - $15,000 | +39.7%After the saleS&P 500 -18.3% · +58.0 pts vs S&P 500Price history ends Oct 27, 2022 | Jan 14, 2022 | Jan 21, 2022 | 7d |
| GVAGRANITE CONSTRUCTION INCORPORATEDSpouseIndustrials | Stock | Sale | $1,001 - $15,000 | +179.0%After the saleS&P 500 +63.5% · +115.4 pts vs S&P 500 | Jan 14, 2022 | Jan 21, 2022 | 7d |
| METASpouseCommunication Services | Stock | Sale | $15,001 - $50,000 | +93.6%After the saleS&P 500 +63.5% · +30.1 pts vs S&P 500 | Jan 14, 2022 | Jan 21, 2022 | 7d |
| HEALTH FUSIONJointAs filed: PRIVATE PLACEMENT | Other | Sale | $15,001 - $50,000 | n/a | May 15, 2017 | Jul 23, 2017 | 69d |
| SOLAZYME, INC.SpouseOther | Stock | Sale | $1,001 - $15,000 | n/a | Apr 21, 2017 | Jul 18, 2017 | 88d |
| HEALTHFUSIONJointAs filed: SALE OF STOCK | Other | Sale | $15,001 - $50,000 | n/a | Jan 21, 2016 | Jul 18, 2017 | 544d |
| SZYMSOLAZYME, INC.JointOther | Stock | Purchase | $1,001 - $15,000 | +6.2%S&P 500 +8.7% · -2.5 pts vs S&P 500Price history ends earlier | Jan 8, 2016 | Jul 18, 2017 | 557d |
| HEALTHFUSIONJointAs filed: SALE OF STOCK OPTIONS. THESE WERE CREATED IN THE PROCESS OF THE SALE OF THE COMPANY. I WAS UNAWARE THAT THESE… | Other | Sale | $250,001 - $500,000 | n/a | Jan 5, 2016 | Jul 18, 2017 | 560d |
No disclosures of that kind among the 9 rows shown.
Showing the 9 most recent disclosures. Lines for the same asset, day, band and action are shown once and marked with the number of lines. All of John Garamendi's trades in the browser, every line of every report.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Under each figure: the S&P 500 over the same window, and the gap between the stock and the index in percentage points. A disclosure carries a band, not a fill. After a sale the stock's move keeps its sign, so a positive number means the stock kept rising after the sale. An option row carries the underlying stock's move, not the option's value. Where a ticker stopped trading the row says when its price history ends; where the company trades on under a new ticker the figure is priced under that one. Estimates; n/a where we hold no figure for the row.
Year by year
buy volume against sale and exchange volume · range midpoints- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
Disclosed volume per year the member traded, 2016 to 2022. A filing gives a range, not an amount, so each bar sums the midpoints of the ranges disclosed that year: a $1,001 to $15,000 line counts as $8,000. The sale side also counts exchanges, including shares received in a spin-off or merger.
Where the disclosed trading sits
by dollar volume tradedGetSignal pushes each new disclosure to your phone as it lands, with the full history and every other member. Free on iOS and Android.
Questions
How many stock trades has John Garamendi disclosed?
John Garamendi has disclosed 9 transactions under the STOCK Act. This page lists the 9 most recent, covering Jan 5, 2016 to Jan 14, 2022.
How long does John Garamendi take to report a trade?
In the filings on record the median gap between a trade and its disclosure is 69 days. The STOCK Act allows up to 45.
Which accounts do John Garamendi's disclosures name?
Of the 9 disclosures shown, 5 name a spouse's account and 4 a joint account. The account is whatever the filer wrote on the disclosure; a spouse's or a joint account is disclosed under the member's name, as the STOCK Act requires.
Where does the estimated net worth on this page come from?
A model's estimate, not a figure the member filed. Reports give every asset and debt as a range, so the model takes a value inside each range and subtracts debts. We round it because the top range has no upper limit. It covers only what the reports carry and is not a measure of anyone's wealth. The methodology page sets out how it is built and what it leaves out.
How have the stocks moved since John Garamendi's trades?
Across the 3 priced rows shown, the median stock move from the trade date to the latest close we hold (figures as of Oct 26, 2026) is +93.6%. 2 rows whose price history ends earlier are left out of it. That figure is an estimate describing the stock after each trade, not the member's result: a disclosure carries a band, not a fill, a sale keeps the same sign, and an option row carries the underlying stock's move. 4 of the rows shown have no figure in our data.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
A disclosure is a record of a transaction, not evidence of anything else, and nothing here is investment advice. Sourcing and the limits of this data are on the methodology page. How these reports work is explained in our guide to STOCK Act reports.
Data as of Oct 26, 2026.